Eric Song

Eric Song currently serves as the Executive Director of Biometrics at Immunome, Inc., starting in June 2024. Prior to this role, Eric held the same position at ProfoundBio from April 2023 to June 2024 and served as Senior Director of Biostatistics at Neoleukin Therapeutics from October 2021 to March 2023. Eric's extensive experience includes positions at Seagen as Senior Director of Biostatistics, where responsibilities also encompassed Director and Associate Director roles, as well as contributions as Principal Statistician and various positions within Takeda. Eric began a career in the financial sector as a Credit Analyst at HSBC before transitioning to statistical roles in the biopharmaceutical industry. Educational qualifications include a PhD in Statistics from Northwestern University, an MS in Applied Statistics from Bowling Green State University, and a Bachelor's Degree in Management Science from Fudan University.